| Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
| FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
| TSHR |
thyroid stimulating hormone receptor, transcript variant 1 |
FXC01753
|
FHC01753
|
FNC01753N
|
FNC01753C
|
| IFNA16 |
interferon, alpha 16 |
FXC02322
|
FHC02322
|
FNC02322N
|
FNC02322C
|
| IFNA1 |
interferon, alpha 1 |
FXC03299
|
FHC03299
|
FNC03299N
|
FNC03299C
|
| ZNF395 |
zinc finger protein 395 |
FXC03445
|
FHC03445
|
FNC03445N
|
FNC03445C
|
| FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
| IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
| CHGA |
chromogranin A, transcript variant 1 |
FXC07948
|
FHC07948
|
FNC07948N
|
FNC07948C
|
| HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
| CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
| FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
| ELF2 |
E74-like factor 2 (ets domain transcription factor), transcript variant 2 |
FXC09540
|
FHC09540
|
FNC09540N
|
FNC09540C
|
| GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
FXC10250
|
FHC10250
|
FNC10250N
|
FNC10250C
|
| CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
| HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
| HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
| PRF1 |
perforin 1 (pore forming protein), transcript variant 1 |
FXC11041
|
FHC11041
|
FNC11041N
|
FNC11041C
|
| HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
| SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
| CGA |
glycoprotein hormones, alpha polypeptide, transcript variant 2 |
FXC12142
|
FHC12142
|
FNC12142N
|
FNC12142C
|
| TPO |
thyroid peroxidase |
FXC15889
|
FHC15889
|
FNC15889N
|
FNC15889C
|
| IFNA13 |
interferon, alpha 13 |
FXC15894
|
FHC15894
|
FNC15894N
|
FNC15894C
|
| TSHB |
thyroid stimulating hormone, beta, transcript variant 1 |
FXC20489
|
FHC20489
|
FNC20489N
|
FNC20489C
|
| CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
| CTLA4 |
cytotoxic T-lymphocyte-associated protein 4, transcript variant 1 |
FXC21288
|
FHC21288
|
FNC21288N
|
FNC21288C
|
| CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
| THPO |
thrombopoietin, transcript variant 1 |
FXC21783
|
FHC21783
|
FNC21783N
|
FNC21783C
|
| IFNA21 |
interferon, alpha 21 |
FXC23475
|
FHC23475
|
FNC23475N
|
FNC23475C
|
| IFNA4 |
interferon, alpha 4 |
FXC23476
|
FHC23476
|
FNC23476N
|
FNC23476C
|
| IFNA10 |
interferon, alpha 10 |
FXC23477
|
FHC23477
|
FNC23477N
|
FNC23477C
|
| IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
| IFNA14 |
interferon, alpha 14 |
FXC23479
|
FHC23479
|
FNC23479N
|
FNC23479C
|
| IFNA5 |
interferon, alpha 5 |
FXC23480
|
FHC23480
|
FNC23480N
|
FNC23480C
|
| IFNA6 |
interferon, alpha 6 |
FXC23481
|
FHC23481
|
FNC23481N
|
FNC23481C
|
| IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
| IFNA8 |
interferon, alpha 8 |
FXC23483
|
FHC23483
|
FNC23483N
|
FNC23483C
|
| CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
| RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
| IFNA7 |
interferon, alpha 7 |
FXC29362
|
FHC29362
|
FNC29362N
|
FNC29362C
|
| IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
| IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
| IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
| STAT1 |
signal transducer and activator of transcription 1, 91kDa |
FXC01313
|
FHC01313
|
FNC01313N
|
FNC01313C
|
| STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced, transcript variant 2 |
FXC01445
|
FHC01445
|
FNC01445N
|
FNC01445C
|
| STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor), transcript variant 2 |
FXC01466
|
FHC01466
|
FNC01466N
|
FNC01466C
|
| JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
| FOXP3 |
forkhead box P3, transcript variant 1 |
FXC02319
|
FHC02319
|
FNC02319N
|
FNC02319C
|
| TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
| SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
| GATA3 |
GATA binding protein 3, transcript variant 2 |
FXC02784
|
FHC02784
|
FNC02784N
|
FNC02784C
|
| SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
| IL23A |
interleukin 23, alpha subunit p19 |
FXC03630
|
FHC03630
|
FNC03630N
|
FNC03630C
|
| IFNGR1 |
interferon gamma receptor 1 |
FXC03908
|
FHC03908
|
FNC03908N
|
FNC03908C
|
| IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
FXC05491
|
FHC05491
|
FNC05491N
|
FNC05491C
|
| IL13 |
interleukin 13 |
FXC05505
|
FHC05505
|
FNC05505N
|
FNC05505C
|
| IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
| IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
| IL2RG |
interleukin 2 receptor, gamma |
FXC05514
|
FHC05514
|
FNC05514N
|
FNC05514C
|
| RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
| IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
| NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
| IL21R |
interleukin 21 receptor, transcript variant 1 |
FXC08180
|
FHC08180
|
FNC08180N
|
FNC08180C
|
| HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
| IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
| STAT4 |
signal transducer and activator of transcription 4, transcript variant 1 |
FXC09368
|
FHC09368
|
FNC09368N
|
FNC09368C
|
| RORC |
RAR related orphan receptor C, transcript variant 1 |
FXC09376
|
FHC09376
|
FNC09376N
|
FNC09376C
|
| TLR2 |
toll-like receptor 2 |
FXC10299
|
FHC10299
|
FNC10299N
|
FNC10299C
|
| HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
| HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
| IL12A |
interleukin 12A |
FXC10673
|
FHC10673
|
FNC10673N
|
FNC10673C
|
| TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
| NOD2 |
nucleotide-binding oligomerization domain containing 2, transcript variant 1 |
FXC11015
|
FHC11015
|
FNC11015N
|
FNC11015C
|
| HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
| SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
| NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
| TLR4 |
toll-like receptor 4, transcript variant 1 |
FXC12088
|
FHC12088
|
FNC12088N
|
FNC12088C
|
| NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1, transcript variant 1 |
FXC12349
|
FHC12349
|
FNC12349N
|
FNC12349C
|
| IL12RB1 |
interleukin 12 receptor, beta 1, transcript variant 1 |
FXC12558
|
FHC12558
|
FNC12558N
|
FNC12558C
|
| TLR5 |
toll-like receptor 5 |
FXC16598
|
FHC16598
|
FNC16598N
|
FNC16598C
|
| IL23R |
interleukin 23 receptor |
FXC20351
|
FHC20351
|
FNC20351N
|
FNC20351C
|
| IL18R1 |
interleukin 18 receptor 1, transcript variant 1 |
FXC21121
|
FHC21121
|
FNC21121N
|
FNC21121C
|
| IL18RAP |
interleukin 18 receptor accessory protein |
FXC21122
|
FHC21122
|
FNC21122N
|
FNC21122C
|
| IL21 |
interleukin 21, transcript variant 1 |
FXC22046
|
FHC22046
|
FNC22046N
|
FNC22046C
|
| IL12B |
interleukin 12B |
FXC22371
|
FHC22371
|
FNC22371N
|
FNC22371C
|
| IL17A |
interleukin 17A |
FXC22655
|
FHC22655
|
FNC22655N
|
FNC22655C
|
| IL17F |
interleukin 17F |
FXC22656
|
FHC22656
|
FNC22656N
|
FNC22656C
|
| IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
| IL22 |
interleukin 22 |
FXC24804
|
FHC24804
|
FNC24804N
|
FNC24804C
|
| TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
| RORA |
RAR related orphan receptor A, transcript variant 2 |
FXC25414
|
FHC25414
|
FNC25414N
|
FNC25414C
|
| RORA |
RAR-related orphan receptor A, transcript variant 4 |
FXC25415
|
FHC25415
|
FNC25415N
|
FNC25415C
|
| IL4R |
interleukin 4 receptor, transcript variant 1 |
FXC25645
|
FHC25645
|
FNC25645N
|
FNC25645C
|
| TBX21 |
T-box 21 |
FXC26082
|
FHC26082
|
FNC26082N
|
FNC26082C
|
| TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
| RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
| IL18 |
interleukin 18, transcript variant 1 |
FXC30506
|
FHC30506
|
FNC30506N
|
FNC30506C
|
| IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
| IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
| IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
| C4A |
complement component 4A (Rodgers blood group), transcript variant 1 |
FXC00323
|
FHC00323
|
FNC00323N
|
FNC00323C
|
| HIST1H2AC |
histone cluster 1, H2ac |
FXC01399
|
FHC01399
|
FNC01399N
|
FNC01399C
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
| HNRNPC |
heterogeneous nuclear ribonucleoprotein C (C1/C2), transcript variant 1 |
FXC02140
|
FHC02140
|
FNC02140N
|
FNC02140C
|
| HIST1H2BD |
histone cluster 1, H2bd, transcript variant 1 |
FXC02237
|
FHC02237
|
FNC02237N
|
FNC02237C
|
| HIST1H3J |
histone cluster 1, H3j |
FXC02310
|
FHC02310
|
FNC02310N
|
FNC02310C
|
| HIST1H4K |
histone cluster 1, H4k |
FXC02328
|
FHC02328
|
FNC02328N
|
FNC02328C
|
| HIST2H3C |
histone cluster 2, H3c |
FXC02449
|
FHC02449
|
FNC02449N
|
FNC02449C
|
| TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
| H3F3B |
H3 histone, family 3B (H3.3B) |
FXC02611
|
FHC02611
|
FNC02611N
|
FNC02611C
|
| SNRPB |
small nuclear ribonucleoprotein polypeptides B and B1, transcript variant 2 |
FXC02710
|
FHC02710
|
FNC02710N
|
FNC02710C
|
| SNRPD3 |
small nuclear ribonucleoprotein D3 polypeptide 18kDa, transcript variant 1 |
FXC02860
|
FHC02860
|
FNC02860N
|
FNC02860C
|
| H2AFX |
H2A histone family, member X |
FXC02977
|
FHC02977
|
FNC02977N
|
FNC02977C
|
| FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
FXC03501
|
FHC03501
|
FNC03501N
|
FNC03501C
|
| SSB |
Sjogren syndrome antigen B (autoantigen La), transcript variant 1 |
FXC03583
|
FHC03583
|
FNC03583N
|
FNC03583C
|
| TRIM21 |
tripartite motif containing 21 |
FXC03697
|
FHC03697
|
FNC03697N
|
FNC03697C
|
| HIST4H4 |
histone cluster 4, H4 |
FXC03890
|
FHC03890
|
FNC03890N
|
FNC03890C
|
| C1QC |
complement component 1, q subcomponent, C chain, transcript variant 2 |
FXC04335
|
FHC04335
|
FNC04335N
|
FNC04335C
|
| HIST1H4E |
histone cluster 1, H4e |
FXC05389
|
FHC05389
|
FNC05389N
|
FNC05389C
|
| HIST1H2AH |
histone cluster 1, H2ah |
FXC05427
|
FHC05427
|
FNC05427N
|
FNC05427C
|
| HIST1H2BK |
histone cluster 1, H2bk, transcript variant 2 |
FXC05625
|
FHC05625
|
FNC05625N
|
FNC05625C
|
| HIST1H3D |
histone cluster 1, H3d |
FXC05653
|
FHC05653
|
FNC05653N
|
FNC05653C
|
| SNRPD1 |
small nuclear ribonucleoprotein D1 polypeptide 16kDa, transcript variant 1 |
FXC06920
|
FHC06920
|
FNC06920N
|
FNC06920C
|
| SNRPD2 |
small nuclear ribonucleoprotein D2 polypeptide 16.5kDa, transcript variant 1 |
FXC06921
|
FHC06921
|
FNC06921N
|
FNC06921C
|
| IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
| PSMA7 |
proteasome subunit alpha 7 |
FXC08190
|
FHC08190
|
FNC08190N
|
FNC08190C
|
| ACTN4 |
actinin, alpha 4 |
FXC08216
|
FHC08216
|
FNC08216N
|
FNC08216C
|
| HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
| CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
| CTSG |
cathepsin G |
FXC08744
|
FHC08744
|
FNC08744N
|
FNC08744C
|
| AKR1C1 |
aldo-keto reductase family 1, member C1 |
FXC08783
|
FHC08783
|
FNC08783N
|
FNC08783C
|
| ACTN1 |
actinin, alpha 1, transcript variant 2 |
FXC08813
|
FHC08813
|
FNC08813N
|
FNC08813C
|
| HIST1H2AG |
histone cluster 1, H2ag |
FXC08853
|
FHC08853
|
FNC08853N
|
FNC08853C
|
| H3F3A |
H3 histone, family 3A |
FXC09287
|
FHC09287
|
FNC09287N
|
FNC09287C
|
| HIST1H2AM |
histone cluster 1, H2am |
FXC09454
|
FHC09454
|
FNC09454N
|
FNC09454C
|
| C6 |
complement component 6, transcript variant 1 |
FXC09582
|
FHC09582
|
FNC09582N
|
FNC09582C
|
| TROVE2 |
TROVE domain family, member 2, transcript variant 2 |
FXC09626
|
FHC09626
|
FNC09626N
|
FNC09626C
|
| C1QB |
complement component 1, q subcomponent, B chain |
FXC09947
|
FHC09947
|
FNC09947N
|
FNC09947C
|
| H2AFZ |
H2A histone family, member Z |
FXC10089
|
FHC10089
|
FNC10089N
|
FNC10089C
|
| C9 |
complement component 9 |
FXC10125
|
FHC10125
|
FNC10125N
|
FNC10125C
|
| CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
| FCGR3A |
Fc fragment of IgG, low affinity IIIa, receptor (CD16a), transcript variant 1 |
FXC10547
|
FHC10547
|
FNC10547N
|
FNC10547C
|
| HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
| HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
| HIST1H4B |
histone cluster 1, H4b |
FXC10595
|
FHC10595
|
FNC10595N
|
FNC10595C
|
| C1R |
complement component 1, r subcomponent |
FXC10857
|
FHC10857
|
FNC10857N
|
FNC10857C
|
| HIST2H2AA3 |
histone cluster 2, H2aa3 |
FXC10911
|
FHC10911
|
FNC10911N
|
FNC10911C
|
| HIST1H4D |
histone cluster 1, H4d |
FXC10917
|
FHC10917
|
FNC10917N
|
FNC10917C
|
| C7 |
complement component 7 |
FXC10986
|
FHC10986
|
FNC10986N
|
FNC10986C
|
| ACTN2 |
actinin, alpha 2, transcript variant 1 |
FXC11021
|
FHC11021
|
FNC11021N
|
FNC11021C
|
| C2 |
complement component 2, transcript variant 1 |
FXC11038
|
FHC11038
|
FNC11038N
|
FNC11038C
|
| HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
| FCGR2A |
Fc fragment of IgG, low affinity IIa, receptor (CD32), transcript variant 2 |
FXC11459
|
FHC11459
|
FNC11459N
|
FNC11459C
|
| CXCL10 |
chemokine (C-X-C motif) ligand 10 |
FXC11687
|
FHC11687
|
FNC11687N
|
FNC11687C
|
| SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
| H2AFY2 |
H2A histone family, member Y2 |
FXC11788
|
FHC11788
|
FNC11788N
|
FNC11788C
|
| H2AFY |
H2A histone family, member Y, transcript variant 2 |
FXC12002
|
FHC12002
|
FNC12002N
|
FNC12002C
|
| HIST1H3A |
histone cluster 1, H3a |
FXC15886
|
FHC15886
|
FNC15886N
|
FNC15886C
|
| C1QA |
complement component 1, q subcomponent, A chain |
FXC20133
|
FHC20133
|
FNC20133N
|
FNC20133C
|
| HIST2H2BE |
histone cluster 2, H2be |
FXC20523
|
FHC20523
|
FNC20523N
|
FNC20523C
|
| HIST2H2AC |
histone cluster 2, H2ac |
FXC20524
|
FHC20524
|
FNC20524N
|
FNC20524C
|
| HIST3H2A |
histone cluster 3, H2a |
FXC20858
|
FHC20858
|
FNC20858N
|
FNC20858C
|
| CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
| CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
| HIST1H2BA |
histone cluster 1, H2ba |
FXC22465
|
FHC22465
|
FNC22465N
|
FNC22465C
|
| HIST1H4C |
histone cluster 1, H4c |
FXC22484
|
FHC22484
|
FNC22484N
|
FNC22484C
|
| HIST1H2BG |
histone cluster 1, H2bg |
FXC22490
|
FHC22490
|
FNC22490N
|
FNC22490C
|
| HIST1H2AE |
histone cluster 1, H2ae |
FXC22491
|
FHC22491
|
FNC22491N
|
FNC22491C
|
| HIST1H3E |
histone cluster 1, H3e |
FXC22492
|
FHC22492
|
FNC22492N
|
FNC22492C
|
| HIST1H3G |
histone cluster 1, H3g |
FXC22497
|
FHC22497
|
FNC22497N
|
FNC22497C
|
| HIST1H2BJ |
histone cluster 1, H2bj |
FXC22510
|
FHC22510
|
FNC22510N
|
FNC22510C
|
| HIST1H4I |
histone cluster 1, H4i |
FXC22511
|
FHC22511
|
FNC22511N
|
FNC22511C
|
| C8G |
complement component 8, gamma polypeptide |
FXC23720
|
FHC23720
|
FNC23720N
|
FNC23720C
|
| IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
| CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
| HIST2H4A |
histone cluster 2, H4a |
FXC27695
|
FHC27695
|
FNC27695N
|
FNC27695C
|
| C1S |
complement component 1, s subcomponent, transcript variant 2 |
FXC28104
|
FHC28104
|
FNC28104N
|
FNC28104C
|
| RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
| H2BFWT |
H2B histone family, member W, testis-specific |
FXC29462
|
FHC29462
|
FNC29462N
|
FNC29462C
|
| C8B |
complement component 8, beta polypeptide, transcript variant 1 |
FXC31629
|
FHC31629
|
FNC31629N
|
FNC31629C
|
| C3 |
complement component 3 |
FXC31634
|
FHC31634
|
FNC31634N
|
FNC31634C
|
